Skip to main content
Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.45
-0.75 (-1.82%)
At close: Dec 5, 2025

Medigen Vaccine Biologics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
13,29811,85123,03522,78563,65321,743
Upgrade
Market Cap Growth
5.22%-48.55%1.10%-64.20%192.75%388.97%
Upgrade
Enterprise Value
11,92310,38221,27120,54062,66022,145
Upgrade
Last Close Price
40.4536.0570.1069.50200.9169.21
Upgrade
PE Ratio
----45.14-
Upgrade
PS Ratio
22.3519.5759.1262.4219.401889.56
Upgrade
PB Ratio
3.693.085.994.5313.616.92
Upgrade
P/TBV Ratio
3.713.106.054.5713.777.06
Upgrade
P/FCF Ratio
-1835.64--142.64-
Upgrade
P/OCF Ratio
554.03290.80--109.77-
Upgrade
EV/Sales Ratio
20.0417.1454.5956.2719.101924.50
Upgrade
EV/EBITDA Ratio
----58.45-
Upgrade
EV/EBIT Ratio
----65.02-
Upgrade
EV/FCF Ratio
-421.511608.05--140.41-
Upgrade
Debt / Equity Ratio
0.080.090.510.390.040.06
Upgrade
Debt / EBITDA Ratio
----0.17-
Upgrade
Debt / FCF Ratio
-52.50--0.42-
Upgrade
Asset Turnover
0.140.120.060.060.750.00
Upgrade
Inventory Turnover
0.580.500.250.762.840.09
Upgrade
Quick Ratio
10.989.541.9912.486.5411.58
Upgrade
Current Ratio
14.1211.942.2115.388.4812.48
Upgrade
Return on Equity (ROE)
-4.44%-2.09%-26.14%-30.39%36.08%-29.91%
Upgrade
Return on Assets (ROA)
-2.50%-1.74%-11.29%-15.18%13.71%-16.55%
Upgrade
Return on Capital (ROIC)
-2.60%-1.82%-11.85%-16.21%14.71%-17.38%
Upgrade
Return on Capital Employed (ROCE)
-4.30%-3.50%-29.60%-22.00%19.80%-22.90%
Upgrade
Earnings Yield
-1.25%-0.68%-5.04%-6.47%2.22%-3.10%
Upgrade
FCF Yield
-0.21%0.05%-2.26%-5.94%0.70%-3.17%
Upgrade
Buyback Yield / Dilution
-0.01%-0.10%-1.50%-0.73%-15.82%-20.08%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.